Response of induced bone defects in horses to collagen matrix containing the human parathyroid hormone gene
Authors:
- Alicia L. BertoneABAlicia L. Bertone
- Erik R. WisnerEWErik R. Wisner
- Stephen E. WeisbrodeSWStephen E. Weisbrode
- 1 September 2004
- journal article
- research article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 65 (9) , 1223-1232
Abstract
Objective—To determine whether human parathyroid hormone (hPTH) gene in collagen matrix could safely promote bone formation in diaphyseal or subchondral bones of horses. Animals—8 clinically normal adult horses. Procedure—Amount, rate, and quality of bone healing for 13 weeks were determined by use of radiography, quantitative computed tomography, and histomorphometric analysis. Diaphyseal cortex and subchondral bone defects of metacarpi were filled with hPTH1-34 gene-activated matrix (GAM) or remained untreated. Joints were assessed on the basis of circumference, synovial fluid analysis, pain on flexion, lameness, and gross and histologic examination. Results—Bone volume index was greater for cortical defects treated with hPTH1-34 GAM, compared with untreated defects. Bone production in cortical defects treated with hPTH1-34 GAM positively correlated with native bone formation in untreated defects. In contrast, less bone was detected in hPTH1-34 GAM-treated subchondral bone defects, compared with untreated defects, and histology confirmed poorer healing and residual collagen sponge. Conclusions and Clinical Relevance—Use of hPTH1-34 GAM induced greater total bone, specifically periosteal bone, after 13 weeks of healing in cortical defects of horses. The hPTH1-34 GAM impeded healing of subchondral bone but was biocompatible with joint tissues. Promotion of periosteal bone formation may be beneficial for healing of cortical fractures in horses, but the delay in onset of bone formation may negate benefits. The hPTH1-34 GAM used in this study should not be placed in articular subchondral bone defects, but contact with articular surfaces is unlikely to cause short-term adverse effects. (Am J Vet Res 2004;65:1223–1232)Keywords
This publication has 62 references indexed in Scilit:
- Rat strain differences in the ectopic osteogenic potential of recombinant human BMP adenovirusesMolecular Therapy, 2003
- Recombinant human PTH 1-34 (Forteo): an anabolic drug for osteoporosis.Cleveland Clinic Journal of Medicine, 2003
- Sustained Effects of Gene-Activated Matrices after CNS InjuryMolecular and Cellular Neuroscience, 2001
- The Influence of Combined Parathyroid Hormone and Growth Hormone Treatment on Cortical Bone in Aged Ovariectomized RatsJournal of Bone and Mineral Research, 2000
- Anabolic Effects of Human Biosynthetic Parathyroid Hormone Fragment (1–34), LY333334, on Remodeling and Mechanical Properties of Cortical Bone in RabbitsJournal of Bone and Mineral Research, 1999
- Parathyroid Hormone and Mechanical Usage Have a Synergistic Effect in Rat Tibial Diaphyseal Cortical BoneJournal of Bone and Mineral Research, 1999
- An Intact N Terminus Is Required for the Anabolic Action of Parathyroid Hormone on Adult Female RatsJournal of Bone and Mineral Research, 1997
- Parathyroid hormone (1–34) increases vertebral bone mass, compressive strength, and quality in old ratsBone, 1995
- Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized ratsBone, 1995
- Estimation of material properties in the equine metacarpus with use of quantitative computed tomographyJournal of Orthopaedic Research, 1994